Free shipping on all orders over $ 500


Cat. No. M1755
WYE-354 Structure
Size Price Availability Quantity
10mg USD 165 In stock
50mg USD 620 In stock
Bulk Inquiry?

Quality Control
Biological Activity

WYE-354 is a potent and ATP competitive inhibitor of mTOR (IC50 = 5 nM), with significant selectivity over PI3K isofoms (>100-fold). WYE-354 is equally potent against mTORC1 and mTORC2 activities in HEK293 immune complex kinase assays using S6K and Akt as the respective substrate (IC50 <200 nM) and effectively blocks cellular phosphorylation of S6K on T389 and Akt on S473 both in cultures and in a murine xenograft model, resulting in a significant suppression of PC3MM2-derived tumor growth (by 86% on day 7; 50 mg/kg, i.p twice per day) in vivo.

Cell Experiment
Cell lines Cell lines of Rat1, HEK293, MDA-MB-361, MDA-MB-468, MDA-MB-231, LNCap, DU145, U87MG, A498, HCT116, and HT29
Preparation method Tumor cell growth assays.
Concentrations 0~100 μ M
Incubation time 3 days
Animal Experiment
Animal models PC3MM2 tumors xenograft in BALB/c nu/nu female mice
Formulation formulated in 5% ethanol, 5% polysorbate 80, 5% polyethylene glycol-400
Dosages a single i.p. injection with 50 mg/kg
Administration i.p.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 495.5
Formula C24H29N7O5
CAS Number 1062169-56-5
Purity 100.00%
Solubility DMSO
Storage at -20°C

Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.
Wahdan-Alaswad RS et al. Mol Cancer Res. 2012 Jun;10(6):821-33. PMID: 22452883.

Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
Yu K et al. Cancer Res. 2009 Aug 1;69(15):6232-40. PMID: 19584280.

Related mTOR Products

Zotarolimus (ABT-578) is an analogue of rapamycin, and inhibits FKBP-12 binding with IC50 of 2.8 nM.


LY303511 is a structural analogue of LY294002, which does not inhibit PI3K, increased homotypic GJIC.


Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 μM.


WYE-125132 is a highly potent, ATP-competitive mTOR inhibitor with IC50 of 0.19 nM; highly selective for mTOR versus PI3Ks or PI3K-related kinases hSMG1 and ATR.


AZD2014 is a novel dual mTORC1 and mTORC2 inhibitor with potential antineoplastic activity.

Abmole Inhibitor Catalog 2017

Keywords: WYE-354 supplier, mTOR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.